Academic Scientists Launch Into 1993-94 School Year With Little Hope Of Easing Serious Funding Problems

On campuses across the United States, academic scientists and research administrators are beginning the 1993-94 school year with no expectations of relief from the fiscal and regulatory difficulties that have marked the past several autumns. States continue to cut back on support for public and private colleges and universities; moreover, the pool of federal funding is not growing sufficiently to keep up with the increased numbers of scientists vying for grants to support their research. "

Written byBarbara Spector
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

"There's a level of acceptance on our campuses" that the funding situation is not going to improve, says Cornelius Pings, president of the Association of American Universities (AAU).

To make matters worse, research administrators say, the paperwork required to satisfy government safety, cost-accounting, and animal-care regulations is mushrooming. At the same time, stiffer indirect-costs restrictions prohibit schools from receiving government reimbursement for the hours spent on such time- consuming labor.

"It's a catch between a rock and a hard place," says Earl Friese, a materials scientist who is director of sponsored research at the California Institute of Technology. "We're required to do more administration--which costs more --but the government says, `We're not going to pay for it.'<|>"

The much-publicized 1991 investigation into accusations that Stanford University misused millions of dollars in federal funds has changed the way university research is regarded by Congress, says Suzanne Polmar, a biologist who is ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies